ASSET PURCHASE AGREEMENT by and among K-V PHARMACEUTICAL COMPANY, NESHER PHARMACEUTICALS INC., DRUGTECH CORPORATION and ZYDUS PHARMACEUTICALS (USA), INC. and ZYNESHER PHARMACEUTICALS (USA) LLC dated as of June 17, 2011Asset Purchase Agreement • July 11th, 2011 • Zeratech Technologies USA, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 11th, 2011 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into as of June 17, 2011, by and among Zydus Pharmaceuticals (USA), Inc., a New Jersey corporation (“Buyer Parent”), Zynesher Pharmaceuticals (USA) LLC, a Missouri limited liability company and wholly owned subsidiary of Buyer Parent (“Buyer Sub” and, collectively with Buyer Parent, “Buyer”), K-V Pharmaceutical Company, a Delaware corporation (“KV”), Nesher Pharmaceuticals Inc., a Delaware corporation and a wholly owned subsidiary of KV (“Nesher”), and DrugTech Corporation, a Delaware corporation and a wholly owned subsidiary of KV (“DrugTech” and, collectively with KV and Nesher, “Sellers”).